Cited by 60Adenosine and Purinergic SignalingParkinson's Disease Mechanisms and TreatmentsNeuroinflammation and Neurodegeneration Mechanisms

P2Y6 and P2X7 Receptor Antagonism Exerts Neuroprotective/ Neuroregenerative Effects in an Animal Model of Parkinson’s Disease

Open access
Oliveira-Giacomelli, Ágatha, M. Albino, Carolina, de Souza, Hellio Danny Nóbrega, Corrêa-Velloso, Juliana, de Jesus Santos, Ana Paula, Baranova, Juliana, Ulrich, Henning·2019·Frontiers in Cellular Neuroscience

Abstract

Parkinson’s disease is a neurodegenerative disorder characterized by decreased dopamine bioavailability in the substantia nigra and the striatum. Taking into account that ATP and its metabolites are intensely released in the 6-hydroxydopamine (6-OHDA) animal model of Parkinson’s disease, screening of purinergic receptor gene expression was performed. Effects of pharmacological P2Y6 or P2X7 receptor antagonism were studied in preventing or reversing hemiparkinsonian behavior and dopaminergic deficits in this animal model. P2X7 receptor antagonism with Brilliant Blue G at a dose of 75 mg/kg reestablished dopaminergic nigrostriatal pathway rats injured with 6-OHDA. Selective P2Y6 receptor antagonism by MRS2578 prevented dopaminergic neuron death in SH-SY5Y cells in vitro and in vivo in the substantia nigra of rats injured with 6-OHDA. Moreover, in vivo analysis showed that both treatments were accompanied by a reduction of microglial activation in the substantia nigra. Altogether, these data provide evidence that antagonism of P2X7 and P2Y6 receptors results in neuroregenerative and neuroprotective effects, respectively, possibly through modulation of neuroinflammatory responses.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fncel.2019.00476

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In animal models for neurodegeneration, P2X7 receptor antagonism exerted beneficial anti-inflammatory effects, indicating that P2X7 receptor activation and subsequent neuroinflammation is tightly related to neurodegeneration worsening.

    “In animal models for neurodegeneration P2X7 receptor antagonism exerted beneficial anti-inflammatory effects [138, 139], indicating that P2X7 receptor activation and subsequent neuroinflammation is tightly related to neurodegeneration worsening.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 60 · Cited by 60

Research works printed but not linked: 1

  1. Paxinos G. Watson C. (2013). The Rat Brain in Stereotaxic Coordinates: Hard Cover Edition. San Diego, CA: Academic Press.

Authors
Oliveira-Giacomelli, Á., M. Albino, C., de Souza, H. D. N., Corrêa-Velloso, J., de Jesus Santos, A. P., Baranova, J., & Ulrich, H.
Affiliations
Universidade de São Paulo (BR)
Corresponding author
Ulrich, Henning
Venue
Frontiers in Cellular Neuroscience
Published
2019-11-08
Volume
13
Pages
476-476
ISSN
1662-5102 (ISSN-L)
OpenAlex
W2981417829
Cited by
60
References
60
Citations by year
2026: 6 · 2025: 7 · 2024: 12 · 2023: 9 · 2022: 10 · 2021: 10 · 2020: 6
FWCI
4.49
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Cellular Neuroscience (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico (306392/2017-8, 154512/2018-4, 142137/2019-7)
  • Fundação de Amparo à Pesquisa do Estado de São Paulo (2012/50880-4, 2018/07366-4, 2017/24400-9)
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (33002010017PO)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
Parkinson's disease, P2Y6 receptor, P2X7 receptor, 6-hydroxydopamine, dopaminergic neuron death, substantia nigra, nigrostriatal pathway, neuroprotection, nerve regeneration, microglial activation, neuroinflammation, ATP release, Brilliant Blue G, MRS2578, SH-SY5Y cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review